ArticleBlood cancer journal2026
NFκB/IL-6/JAK2/STAT axis in myelofibrosis is a key vulnerability that is targetable and relevant to JAK2 inhibitor treatment resistance.
Huiqin Bian, Naseema Gangat, Na Shen, Jiuxia Pang, David Wald, William Tse, Ayalew Tefferi, Fei Yan, Shujun Liu
Abstract readLetter
In one paragraphArticle in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Huiqin BianDepartment of Medicine, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA.
Na ShenKey laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China.
Jiuxia PangDepartment of Medicine, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA.
William TseDepartment of Medicine, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA.
Fei YanState Key Laboratory of Inorganic Synthesis & Preparative Chemistry, College of Chemistry, Jilin University, Changchun, China. feiyan@jlu.edu.cn.
Funding
The Role of HIF1A-DNMT3A axis in AML1/ETO-Driven Acute MyelogenousLeukemiaR01CA248019 · NCI · UNIVERSITY OF MINNESOTA · PI LIU, SHUJUN · 2021 to 2025
$3.2MRole of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem CellR01CA266256 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, GANG, LIU, SHUJUN · 2022 to 2025
$3.0MTargeting aberrant epigenetics by nanomedicineR01CA149623 · NCI · UNIVERSITY OF MINNESOTA · PI LIU, SHUJUN · 2010 to 2014
$1.8MNCI NIH HHS R01 CA149623NCI NIH HHS R01 CA248019NCI NIH HHS R01 CA266256U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA149623U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA248019U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA266256
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID41526340
PMCPMC12795839
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390